Table 2 |
||||||||
|
Association of CD226 haplotype block in the Fib+ subset of systemic sclerosis patients. |
||||||||
|
rs763361 |
rs34794968 |
rs727088 |
Subgroup |
MAF (%) |
PMH |
PBonf |
OR [CI 95%] |
PBD |
|
|
||||||||
|
Fib+ |
0.40 |
|||||||
|
T |
A |
G |
CTRL |
0.41 |
0.59 |
NS |
0.97 [0.86-1.08] |
0.45 |
|
Fib- |
0.41 |
0.76 |
NS |
0.98 [0.86-1.11] |
0.77 |
|||
|
|
||||||||
|
Fib+ |
0.10 |
|||||||
|
T |
C |
G |
CTRL |
0.08 |
1.59E-02 |
3.18E-02 |
1.27 [1.05-1.54] |
0.48 |
|
Fib- |
0.08 |
0.069 |
NS |
1.24 [0.99-1.56] |
0.51 |
|||
|
|
||||||||
|
Fib+ |
0.50 |
|||||||
|
C |
C |
A |
CTRL |
0.51 |
0.44 |
NS |
0.96 [0.86-1.07] |
0.71 |
|
Fib- |
0.51 |
0.50 |
NS |
0.95 [0.84-1.09] |
0.44 |
|||
|
|
||||||||
|
For the haplotype-specific analyses, the odds ratio (OR) with 95% confidence interval (95% CI) was determined for each allele variant in the haplotype tested against all of the others pooled together using the Mantel-Haenszel test under fixed effects model, considering no single reference haplotype. CTRL, healthy controls; Fib-, lung fibrosis negative SSc patients; Fib+, lung fibrosis positive SSc patients; MAF, minor allele frequency; PBonf, corrected P-value using Bonferroni multiple test correction. |
||||||||
|
Bossini-Castillo et al. Arthritis Research & Therapy 2012 14:R85 doi:10.1186/ar3809 |
||||||||